ProQR’s inventory jumps on expanded RNA deal with Lilly
Shares of ProQR Therapeutics NV PRQR, +78.21% soared 56.3% in premarket buying and selling on Thursday following the firm reported ...
Read moreDetails
Shares of ProQR Therapeutics NV PRQR, +78.21% soared 56.3% in premarket buying and selling on Thursday following the firm reported ...
Read moreDetails
